We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SAKAR.NSE

Price
258.29
Stock movement up
+16.77 (6.94%)
Company name
Sakar Healthcare Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
5.62B
Ent value
6.96B
Price/Sales
3.42
Price/Book
2.08
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
45.29
Forward P/E
-
PEG
-
EPS growth
3.74%
1 year return
-30.77%
3 year return
22.85%
5 year return
34.35%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

SAKAR.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E45.29
Price to OCF63.20
Price to FCF63.20
Price to EBITDA62.36
EV to EBITDA77.28

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales3.42
Price to Book2.08
EV to Sales4.24

FINANCIALS

Per share

Per share data
Current share count21.75M
EPS (TTM)5.59
FCF per share (TTM)4.00

Income statement

Income statement data
Revenue (TTM)1.64B
Gross profit (TTM)335.82M
Operating income (TTM)226.91M
Net income (TTM)124.03M
EPS (TTM)5.59
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)20.45%
Operating margin (TTM)13.82%
Profit margin (TTM)7.55%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash3.20M
Net receivables239.40M
Total current assets804.52M
Goodwill0.00
Intangible assets33.22M
Property, plant and equipment0.00
Total assets4.04B
Accounts payable255.79M
Short/Current long term debt838.74M
Total current liabilities715.16M
Total liabilities1.35B
Shareholder's equity2.69B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)88.89M
Capital expenditures (TTM)0.00
Free cash flow (TTM)88.89M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity4.60%
Return on Assets3.07%
Return on Invested Capital4.09%
Cash Return on Invested Capital2.93%

STOCK INFORMATION

Stock chart

Stock price data
Open239.32
Daily high261.35
Daily low239.01
Daily Volume31K
All-time high442.05
1y analyst estimate-
Beta0.39
EPS (TTM)5.59
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
SAKAR.NSES&P500
Current price drop from All-time high-41.57%-12.89%
Highest price drop-52.10%-56.47%
Date of highest drop28 Mar 20259 Mar 2009
Avg drop from high-19.71%-11.07%
Avg time to new high33 days12 days
Max time to new high486 days1805 days
COMPANY DETAILS
SAKAR.NSE (Sakar Healthcare Limited) company logo
Marketcap
5.62B
Marketcap category
Mid-cap
Description
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Employees
325
Website
https://www.sakarhealthcare.com
Investor relations
-
SEC filings
SAKAR.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved